H.C. Wainwright Has Increased Confidence in Arena Pharma (ARNA) AD Program After KOL Event
Tweet Send to a Friend
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $120.00 price target on Arena Pharma (NASDAQ: ARNA) after a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
